Back
Biomarin Pharmaceutical Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
54
BMRN
Biomarin Pharmaceutical
Last Price:
66.06
Seasonality Move:
13.3%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.62 | Sell |
| 20-day SMA: | 69.09 | Sell |
| 50-day SMA: | 74.56 | Sell |
| 200-day SMA: | 82.71 | Sell |
| 8-day EMA: | 67.29 | Sell |
| 20-day EMA: | 68.99 | Sell |
| 50-day EMA: | 73.26 | Sell |
| 200-day EMA: | 81.42 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.96 | Sell |
| Relative Strength Index (14 RSI): | 29.66 | Sell |
| Chaikin Money Flow: | 826493 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.58 - 70.68) | Sell |
| Bollinger Bands (100): | (71.66 - 88.44) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 66.04 while BMRN 8-day simple moving average is 67.62, which is a Sell signal.
- The stock price of BMRN is 66.04 while Biomarin Pharmaceutical 20-day SMA is 69.09, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 74.56 while BMRN share price is 66.04, making it a Sell technically.
- BMRN stock price is 66.04 and Biomarin Pharmaceutical 200-day simple moving average is 82.71, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
54
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Buy
The current Biomarin Pharmaceutical [BMRN] share price is $66.04. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
12.59B
Price in USD:
66.04
Share Volume:
1.61M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
65.35
Buy
54
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 66.04 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 66.04 while BMRN 8-day exponential moving average is 67.29, which is a Sell signal.
- The stock price of BMRN is 66.04 while Biomarin Pharmaceutical 20-day EMA is 68.99, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 73.26 while BMRN share price is 66.04, making it a Sell technically.
- BMRN stock price is 66.04 and Biomarin Pharmaceutical 200-day simple moving average is 81.42, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -1.96, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 29.66, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (67.58 - 70.68), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (71.66 - 88.44), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.